Cargando…
Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma
BACKGROUND: Systemic chemotherapy or chemoradiation therapy has proven to be effective in treating advanced biliary tract carcinoma (BTC). However, its efficacy in the adjuvant setting remains controversial. Therefore, this study aimed to determine the prognostic significance of genomic biomarkers i...
Autores principales: | Li, Yunfeng, Tan, Chaochao, Yin, Xinmin, Zhu, Siwei, Cai, Rongyao, Liao, Chunhong, Wu, Yifei, Zeng, Qihong, Cai, Chengzhi, Xie, Wang, He, Xiangyu, Wen, Hao‐quan, Lin, Guomin, He, Qingqing, He, Tingting, Gu, Peng, Liu, Chang‐jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469713/ https://www.ncbi.nlm.nih.gov/pubmed/37341068 http://dx.doi.org/10.1002/cam4.6261 |
Ejemplares similares
-
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020) -
Adjuvant Therapy for Resectable Biliary Tract Cancer: A Bayesian Network Analysis
por: Chen, Xiuqiong, et al.
Publicado: (2021) -
Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019) -
Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023) -
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020)